Name: In Vitro Culture for H5N1-Specific Duck T Cells and Detection of Immune Responses Using Intracellular Cytokine Staining Method (Video) | JoVE Journal
Uploaded: 2025-05-30T14:50:00.000+00:00
Duration: 6 min 57 s
Description: Learn to culture H5N1-specific duck T cells in vitro and detect IFN-γ responses using intracellular cytokine staining. This protocol enables quantification of avian T cell immunity for vaccine development.

ai_agent_IP

ai_agent

maintenance

instantTrialDurationMinutes

isBiopharma

enableNewMyJoveSectionDesign

educationFeatures

seoMetaApi

ai_copilot_institution_blacklist

ai_chat_institution_blacklist

freeAccessWindow

ssoRoleCapture

scheduledMaintenanceBanner

joveLabsFeatures

disable_autoplay_for_bots

extended_trial_duration

5 minutes

This work was supported by National Natural Science Foundation of China (32473060 and 32461120064) (to MD and ML); Guangzhou Basic and Applied Basic Research Project (2025A04J5445) (to MD); the Young Scholars of the Yangtze River Scholar Professor Program (2024, Manman Dai); and the Young Peal River Scholar of &#34;Guangdong Special Support Plan&#34;(2024, Manman Dai). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.

All experiments with all available avian influenza A (H5N1) viruses were carried out in an animal biosafety level 3 laboratory and animal facility according to the protocols of South China Agricultural University (CNAS BL0011). All animal research projects were approved by the Institutional Animal Care and Use Committee (identification code 2021f154, July 29, 2021) of the South China Agriculture University. All animal procedures were performed according to the regulations and guidelines established by this committee and international standards for animal welfare. The animals used in this study were 4-week-old domestic mallard ducks (Anas platyrhynchos domestica), including both males and females, with body weights ranging from 500 to 600 g.
1. Duck PBMCs isolation and preparation of a single-cell suspension
<ol>
	<li>Collect 2 mL of heparinized blood from the jugular vein of each duck and transfer into EDTA-containing tubes to prevent coagulation from each individual duck</li>
	<li>Dilute the blood using the provided sample diluent from the lymphocyte isolation kit or PBS. Gently mix by pipetting with a Pasteur pipette. The usual dilution ratio is 1:1 for blood to diluent.</li>
	<li>Transfer an equal volume of lymphocyte separation solution into a centrifuge tube as the diluted blood. Carefully layer the blood suspension on top of the lymphocyte separation solution. Centrifuge the mixture at 400 x g, 25 &#176;C for 15 min, setting the falling acceleration to 1. 
	NOTE: The amount of lymphocyte separation solution should not be less than 4 mL. The components of the lymphocyte separation solution kit can be found in the Table of Materials.</li>
	<li>After centrifugation, observe the four distinct layers in the centrifuge tube from top to bottom. The top layer is the sample diluent, followed by the annular milky white lymphocyte layer, then the separation solution, and the bottom layer consists of red blood cells.</li>
	<li>Carefully use a pipette to collect the second layer, the annular milky white lymphocyte layer, and transfer it into a new centrifuge tube. Add 10 mL of cleaning solution to mix with the cells.</li>
	<li>Centrifuge the sample at 440 x g for 5 min at room temperature. Discard the supernatant, then resuspend the cell pellet in 10 mL of RPMI 1640 medium for cell counting.</li>
	<li>Optional) To further purify the sample, after centrifuging at 440 x g for 5 min, use red blood cell lysis buffer to remove any remaining mixed blood cells.</li>
</ol>
2. In vitro H5N1 AIV-specific T cell culture
<ol>
	<li>Purchase 2-week-old healthy mallard ducks (Sheldrake) from a duck farm and house them in negative-pressure isolators. Confirm that the ducks are negative for AIV by using hemagglutination inhibition (HI) assays prior to the experiment. Infect 4-week-old ducks with H5N1 AIV 1 x 106, with 50% egg infectious dose [EID50]/0.2 mL intranasally.</li>
	<li>Isolate memory PBMCs from H5N1-infected ducks 28 days post-infection, following the method described in step 1. Count cells using a hemocytometer. Dilute the cell suspension at a 1:1 ratio with 0.08% trypan blue and count viable (unstained) cells manually under a light microscope. 
	NOTE: As supported by our previously published study20, peripheral blood mononuclear cells (PBMCs) isolated at 28 days post-infection are considered to be enriched in memory T cells. At this stage, the effector phase has subsided, and memory cell populations are predominant.</li>
	<li>Set the concentration to 3 x 106 cells/mL, ensuring 1 mL of medium is added to each well of the 48-well plate.</li>
	<li>Co-infect the isolated PBMCs with H5N1 avian influenza virus (AIV) to serve as APCs. The viral dose is MOI = 5. Co-culture the PBMCs with the virus for 1 h at 37 &#176;C. Gently shake by hand every 15 min.</li>
	<li>After 1 h of infection, wash the cells 2x with PBS to remove unbound viral particles. Resuspend the washed PBMCs in 1 mL of T cell culture medium and further incubate the suspended cells at 37 &#176;C for 5 h.</li>
	<li>Centrifuge the cells at 440 x g for 5 min at room temperature. Afterward, resuspend the incubated antigen-presenting cells (APCs) in 100 &#181;L of T cell culture medium and add them to the effector cells. The ratio of antigen-presenting cells to effector cells should be 1:5.</li>
	<li>Incubate the cells in a 5% CO2 atmosphere at 37 &#176;C for 14 days. Every 2 days, replace half of the cell culture supernatant with fresh T cell medium by carefully pipetting to ensure even distribution. Discard half of the medium containing the cells, then add an equal volume of new medium.</li>
	<li>On day 7, observe the cells under an optical microscope at 100x.</li>
	<li>Use PBS-treated memory PBMCs as the unstimulated control group.</li>
</ol>
3. Carboxy fluorescein Diacetate Succinimidyl Ester (CFSE) to monitor T cell proliferation
<ol>
	<li>Adjust the cell density to 0.5-1 x 107 cells/mL and resuspend the cells with 5 mL of PBS after centrifugation at 440 x g for 5 min.</li>
	<li>Dilute 10 mM stock to 1 &#181;M CFSE with 5 mL of pre-chilled PBS; operate in the dark.</li>
	<li>Tilt the two centrifuge tubes at 45&#176;, add the CFSE dilution to the cell suspension with a Pasteur pipette, mix well, and place in a 37 &#176;C water bath for 15 min in the dark.</li>
	<li>Wash cells by diluting them in 10 volumes of pre-cooled PBS containing 5% FBS, sediment by centrifugation at 440 x g for 5 min, and discard the supernatant. Repeat the wash 2x.</li>
	<li>Stimulate cells labeled with CFSE in vitro as per step 2. At the completion of the proliferation assay, harvest cells and analyze by flow cytometry.</li>
</ol>
4. Flow cytometric analysis for proliferation of CD8+ T and CD4+ T cells
<ol>
	<li>After 7 days of culture, collect all the cells from each well and divide them into two flow tubes for analysis.</li>
	<li>Transfer the cells to a new centrifuge tube, centrifuge at 440 x g for 5 min at room temperature, and discard the supernatant.</li>
	<li>Add 100&#8239;&#181;L of antibody cocktail (mouse anti-duck CD8, 1:50 or mouse anti-duck CD4, 1:50) and incubate the cells for 30 min in the dark at 4 &#176;C.</li>
	<li>Transfer the cells to a new centrifuge tube, centrifuge at 440 x g for 5 min at room temperature, and discard the supernatant.</li>
	<li>Add 100&#8239;&#181;L of antibody cocktail (FITC-conjugated Goat Anti-Mouse IgG2b, 1:50) and incubate the cells for 30 min in the dark at 4 &#176;C.</li>
	<li>Wash the cells once with 1 mL of PBS by centrifuging at 400 x g for 5 min at 4 &#176;C. Analyze the data using FlowJo software. The gating strategy is shown in Supplementary Figure 1.</li>
</ol>
5. T-cell response by signature gene expression assays using qPCR
<ol>
	<li>Count cells at the end of T-cell culture, collect in 1.5 mL centrifuge tubes, and centrifuge at 400 x g for 5 min. Discard the supernatant carefully.</li>
	<li>RNA extraction 
	NOTE: Extraction can be performed in a fume hood or ultra-clean bench to prevent RNA contamination.
	<ol>
		<li>Lyse the cells using the lysis buffer provided in the kit as per the manufacturer&#39;s instructions. Transfer lysed sample to gDNA-Filter Columns (pre-placed in collection tubes), centrifuge at 13,400 x g for 30 s, discard columns, and collect the filtrate. Add 0.5 volume of absolute ethanol to the filtrate. Mix thoroughly. 
		NOTE: A cloudy solution or precipitate after ethanol addition is normal. Shake and proceed to the next step.</li>
		<li>Transfer the mixture to RNA columns, centrifuge at 13,400 x g for 30 s. Discard filtrate, add 700 &#181;L of Buffer RW1, and centrifuge again.</li>
		<li>Discard filtrate, add 700 &#181;L of Buffer RW2 (with absolute ethanol), and centrifuge. Discard filtrate, add 500 &#181;L of Buffer RW2 (with absolute ethanol), and centrifuge for 2 min. Carefully remove the column from the tube to avoid contamination from the filtrate. Ensure all rinse solutions are removed to prevent interference in downstream reactions.</li>
		<li>Transfer column to a new RNase-free collection tube, add 50-200 &#181;L of RNase-free ddH2O, let it sit at room temperature for 1 min, then centrifuge at 13,400 x g for 1 min to elute RNA. Measure RNA purity and concentration. 
		NOTE: Preheat RNase-free ddH2O to 65 &#176;C for increased yield and perform a second elution if needed.</li>
	</ol>
	</li>
	<li>Synthesize cDNA following the kit instructions. Synthesize the cDNA strand as per the manufacturer&#39;s instructions, adding 5x the amount of reverse transcriptase. Reverse transcribe at 37 &#176;C for 15 min, then 85 &#176;C for 5 s, and cool to 4 &#176;C.</li>
	<li>Set up PCR reaction according to the manufacturer&#39;s protocol.
	<ol>
		<li>In a qPCR tube, combine 10 &#181;L of 2x PCR reaction enzyme mix, 0.4 &#181;L of primer 1, 0.4 &#181;L of primer 2, 1 &#181;L of cDNA template, and 8.2 &#181;L of ddH2O to make a 20 &#181;L mix.</li>
		<li>Run PCR in the real-time quantitative PCR instrument with the following program: 
		Stage 1: 95 &#176;C for 30 s, Rep x 1 
		Stage 2: 95 &#176;C for 3 s, 60 &#176;C for 30 s, Rep x 35 
		Stage 3: 95 &#176;C for 15 s, 60 &#176;C for 60 s, 95 &#176;C for 15 s, Rep x 1</li>
	</ol>
	</li>
</ol>
6. Intracellular Cytokine Staining (ICS)
NOTE: This protocol was developed to assess the effector response of H5N1-specific CD8+ T cells by detecting intracellular IFN-&#947; secretion in ducks.
<ol>
	<li>Culture H5N1-specific T cells in vitro following the procedure described in step 2. Harvest all cells (from each well) after 7 days of culture initiation.</li>
	<li>Incubate the antigen-presenting cells (APCs) as outlined in step 2. Add the incubated APCs and Brefeldin A (1:1,000) to the effector cells and co-incubate for 6 h in a 39 &#176;C incubator.</li>
	<li>Transfer the cells to a new centrifuge tube, centrifuge at 440 x g for 5 min at room temperature, and discard the supernatant.</li>
	<li>Add 100&#8239;&#181;L of antibody cocktail (mouse anti-duck CD8, 1:50) to the cells and incubate for 30 min in the dark at 4 &#176;C.</li>
	<li>Wash the cells by centrifuging at 400 x g for 5 min at 4 &#176;C and resuspend them in 1 mL of PBS. Add an antibody cocktail (FITC-conjugated Goat Anti-Mouse IgG2b, 1:50) and incubate for 30 min in the dark at 4 &#176;C.</li>
	<li>Wash the cells again by centrifuging at 400 x g for 5 min at 4 &#176;C. Discard the supernatant, resuspend the cells in 100 &#181;L of fixation buffer, and incubate for 20-25 min in the dark at 4 &#176;C.</li>
	<li>Wash the cells once more by centrifuging at 400 x g for 5 min at 4 &#176;C. Add 1 mL of 1x permeabilization buffer and wash the cells 2x by centrifugation at 440 x g for 5 min at 4 &#176;C.</li>
	<li>Discard the supernatant, resuspend the cells in 100 &#181;L of permeabilization buffer, and add the antibody (Mouse Anti-Duck IFN-&#947;, 1:10) to the cells. After fixation and membrane permeabilization, incubate the cell-antibody mixture for 30 min in the dark, occasionally shaking during the incubation at 4 &#176;C. 
	NOTE: The Permeabilization/Wash solution is a 10x stock solution and must be diluted with PBS before use.</li>
	<li>Wash the cells once more with 1 mL of PBS by centrifuging at 400 x g for 5 min at 4 &#176;C. Add 100&#8239;&#181;L of antibody cocktail (PE-conjugated Goat Anti-Mouse IgG3, 1:250) and incubate for 30 min in the dark at 4&#176;C.</li>
	<li>Analyze the data using FlowJo software. The gating strategy is shown in Figure 1.</li>
</ol>

<ol><li>Almeida, L., Lochner, M., Berod, L., Sparwasser, T. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Metabolic+pathways+in+T+cell+activation+and+lineage+differentiation%5BTitle%5D)+AND+%22Semin+Immunol%22%5BJournal%5D)">Metabolic pathways in T cell activation and lineage differentiation.</a> Semin Immunol. 28 (5), 514-524 (2016).</li>
<li>Weidle, U. H., Georges, G., Tiefenthaler, G. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((TCR-MHC%2Fpeptide+interaction%3A+prospects+for+new+anti-tumoral+agents%5BTitle%5D)+AND+%22Cancer+Genom+Proteom%22%5BJournal%5D)">TCR-MHC/peptide interaction: prospects for new anti-tumoral agents.</a> Cancer Genom Proteom. 11 (6), 267-277 (2014).</li>
<li>Mazza, C., Malissen, B. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((What+guides+MHC-restricted+TCR+recognition%5BTitle%5D)+AND+%22Semin+Immunol%22%5BJournal%5D)">What guides MHC-restricted TCR recognition.</a> Semin Immunol. 19 (4), 225-235 (2007).</li>
<li>Nel, A. E. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((T-cell+activation+through+the+antigen+receptor.+Part+1%3A+signaling+components%2C+signaling+pathways%2C+and+signal+integration+at+the+T-cell+antigen+receptor+synapse%5BTitle%5D)+AND+%22J+Allergy+Clin+Immunol%22%5BJournal%5D)">T-cell activation through the antigen receptor. Part 1: signaling components, signaling pathways, and signal integration at the T-cell antigen receptor synapse.</a> J Allergy Clin Immunol. 109 (5), 758-770 (2002).</li>
<li>Dai, M., Xu, C., Chen, W., Liao, M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Progress+on+chicken+T+cell+immunity+to+viruses%5BTitle%5D)+AND+%22Cell+Mol+Life+Sci%22%5BJournal%5D)">Progress on chicken T cell immunity to viruses.</a> Cell Mol Life Sci. 76 (14), 2779-2788 (2019).</li>
<li>Deng, G., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((The+role+and+therapeutic+strategies+for+tissue-resident+memory+T+cells%2C+central+memory+T+cells%2C+and+effector+memory+T+cells+in+psoriasis%5BTitle%5D)+AND+%22Immunology%22%5BJournal%5D)">The role and therapeutic strategies for tissue-resident memory T cells, central memory T cells, and effector memory T cells in psoriasis.</a> Immunology. 173 (3), 470-480 (2024).</li>
<li>Corrado, M., Pearce, E. L. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Targeting+memory+T+cell+metabolism+to+improve+immunity%5BTitle%5D)+AND+%22J+Clin+Invest%22%5BJournal%5D)">Targeting memory T cell metabolism to improve immunity.</a> J Clin Invest. 132 (1), 148546(2022).</li>
<li>Liu, X., Li, H., Li, S., Yuan, J., Pang, Y. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Maintenance+and+recall+of+memory+T+cell+populations+against+tuberculosis%3A+Implications+for+vaccine+design%5BTitle%5D)+AND+%22Front+Immunol%22%5BJournal%5D)">Maintenance and recall of memory T cell populations against tuberculosis: Implications for vaccine design.</a> Front Immunol. 14, 1100741(2023).</li>
<li>Zanker, D., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((An+optimized+method+for+establishing+high+purity+murine+CD8%2B+T+cell+cultures%5BTitle%5D)+AND+%22J+Immunol+Methods%22%5BJournal%5D)">An optimized method for establishing high purity murine CD8+ T cell cultures.</a> J Immunol Methods. 387 (1-2), 173-180 (2013).</li>
<li>Yang, W., Chen, X., Hu, H. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((CD4%28%2B%29+T-Cell+Differentiation+In+Vitro%5BTitle%5D)+AND+%22Methods+Mol+Biol%22%5BJournal%5D)">CD4(+) T-Cell Differentiation In Vitro.</a> Methods Mol Biol. 2111, 91-99 (2020).</li>
<li>Jiao, W., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Revealing+novel+CD8%28%2B%29+T-cell+epitopes+from+the+H5N1+avian+influenza+virus+in+HBW%2FB1+haplotype+ducks%5BTitle%5D)+AND+%22Vet+Res%22%5BJournal%5D)">Revealing novel CD8(+) T-cell epitopes from the H5N1 avian influenza virus in HBW/B1 haplotype ducks.</a> Vet Res. 55 (1), 169(2024).</li>
<li>Faulkner, L., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((The+development+of+in+vitro+culture+methods+to+characterize+primary+T-cell+responses+to+drugs%5BTitle%5D)+AND+%22Toxicol+Sci%22%5BJournal%5D)">The development of in vitro culture methods to characterize primary T-cell responses to drugs.</a> Toxicol Sci. 127 (1), 150-158 (2012).</li>
<li>Cimen Bozkus, C., Blazquez, A. B., Enokida, T., Bhardwaj, N. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((A+T-cell-based+immunogenicity+protocol+for+evaluating+human+antigen-specific+responses%5BTitle%5D)+AND+%22STAR+Protoc%22%5BJournal%5D)">A T-cell-based immunogenicity protocol for evaluating human antigen-specific responses.</a> STAR Protoc. 2 (3), 100758(2021).</li>
<li>Masuda, Y., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Biological+effects+of+chicken+type+III+interferon+on+expression+of+interferon-stimulated+genes+in+chickens%3A+comparison+with+type+I+and+type+II+interferons%5BTitle%5D)+AND+%22J+Vet+Med+Sci%22%5BJournal%5D)">Biological effects of chicken type III interferon on expression of interferon-stimulated genes in chickens: comparison with type I and type II interferons.</a> J Vet Med Sci. 74 (11), 1381-1386 (2012).</li>
<li>Ding, H., Wang, G., Yu, Z., Sun, H., Wang, L. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Role+of+interferon-gamma+%28IFN-%CE%B3%29+and+IFN-%CE%B3+receptor+1%2F2+%28IFN%CE%B3R1%2F2%29+in+regulation+of+immunity%2C+infection%2C+and+cancer+development%3A+IFN-%CE%B3-dependent+or+independent+pathway%5BTitle%5D)+AND+%22Biomed+Pharmacother%22%5BJournal%5D)">Role of interferon-gamma (IFN-γ) and IFN-γ receptor 1/2 (IFNγR1/2) in regulation of immunity, infection, and cancer development: IFN-γ-dependent or independent pathway.</a> Biomed Pharmacother. 155, 113683(2022).</li>
<li>Gong, Z., Li, Q., Shi, J., Ren, G. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((An+Artifact+in+Intracellular+Cytokine+Staining+for+Studying+T+Cell+Responses+and+Its+Alleviation%5BTitle%5D)+AND+%22Front+Immunol%22%5BJournal%5D)">An Artifact in Intracellular Cytokine Staining for Studying T Cell Responses and Its Alleviation.</a> Front Immunol. 13, 759188(2022).</li>
<li>Yu, E. D., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Ex+vivo+assays+show+human+gamma-delta+T+cells+specific+for+common+allergens+are+Th1-polarized+in+allergic+donors%5BTitle%5D)+AND+%22Cell+Rep+Methods%22%5BJournal%5D)">Ex vivo assays show human gamma-delta T cells specific for common allergens are Th1-polarized in allergic donors.</a> Cell Rep Methods. 2 (12), 100350(2022).</li>
<li>Grant, E. J., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Broad+CD8%28%2B%29+T+cell+cross-recognition+of+distinct+influenza+A+strains+in+humans%5BTitle%5D)+AND+%22Nat+Commun%22%5BJournal%5D)">Broad CD8(+) T cell cross-recognition of distinct influenza A strains in humans.</a> Nat Commun. 9 (1), 5427(2018).</li>
<li>Letsch, A., Scheibenbogen, C. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Quantification+and+characterization+of+specific+T-cells+by+antigen-specific+cytokine+production+using+ELISPOT+assay+or+intracellular+cytokine+staining%5BTitle%5D)+AND+%22Methods%22%5BJournal%5D)">Quantification and characterization of specific T-cells by antigen-specific cytokine production using ELISPOT assay or intracellular cytokine staining.</a> Methods. 31 (2), 143-149 (2003).</li>
<li>Dai, M., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Duck+CD8%28%2B%29+T+Cell+Response+to+H5N1+Highly+Pathogenic+Avian+Influenza+Virus+Infection+In+Vivo+and+In+Vitro%5BTitle%5D)+AND+%22J+Immunol%22%5BJournal%5D)">Duck CD8(+) T Cell Response to H5N1 Highly Pathogenic Avian Influenza Virus Infection In Vivo and In Vitro.</a> J Immunol. 209 (5), 979-990 (2022).</li>
<li>Jabbari, A., Harty, J. T. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((The+generation+and+modulation+of+antigen-specific+memory+CD8+T+cell+responses%5BTitle%5D)+AND+%22J+Leukoc+Biol%22%5BJournal%5D)">The generation and modulation of antigen-specific memory CD8 T cell responses.</a> J Leukoc Biol. 80 (1), 16-23 (2006).</li>
<li>Puleo, A., Carroll, C., Maecker, H. T., Gupta, R. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Isolation+of+Peripheral+Blood+Mononuclear+Cells+Using+Vacutainer+Cellular+Preparation+Tubes+%28CPT%28TM%29%29%5BTitle%5D)+AND+%22Bio+Protoc%22%5BJournal%5D)">Isolation of Peripheral Blood Mononuclear Cells Using Vacutainer Cellular Preparation Tubes (CPT(TM)).</a> Bio Protoc. 7 (2), e2103(2017).</li>
<li>Chometon, T. Q., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((A+protocol+for+rapid+monocyte+isolation+and+generation+of+singular+human+monocyte-derived+dendritic+cells%5BTitle%5D)+AND+%22PLoS+One%22%5BJournal%5D)">A protocol for rapid monocyte isolation and generation of singular human monocyte-derived dendritic cells.</a> PLoS One. 15 (4), e0231132(2020).</li>
<li>Qin, S., Zhang, Y., Tian, Y., Xu, F., Zhang, P. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Subcellular+metabolomics%3A+Isolation%2C+measurement%2C+and+applications%5BTitle%5D)+AND+%22J+Pharm+Biomed+Anal%22%5BJournal%5D)">Subcellular metabolomics: Isolation, measurement, and applications.</a> J Pharm Biomed Anal. 210, 114557(2022).</li>
<li>Pertoft, H., Johnsson, A., Wärmegård, B., Seljelid, R. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Separation+of+human+monocytes+on+density+gradients+of+Percoll%5BTitle%5D)+AND+%22J+Immunol+Methods%22%5BJournal%5D)">Separation of human monocytes on density gradients of Percoll.</a> J Immunol Methods. 33 (3), 221-229 (1980).</li>
<li>Zanker, D., Waithman, J., Yewdell, J. W., Chen, W. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Mixed+proteasomes+function+to+increase+viral+peptide+diversity+and+broaden+antiviral+CD8%2B+T+cell+responses%5BTitle%5D)+AND+%22J+Immunol%22%5BJournal%5D)">Mixed proteasomes function to increase viral peptide diversity and broaden antiviral CD8+ T cell responses.</a> J Immunol. 191 (1), 52-59 (2013).</li>
<li>Chen, L., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((A+dominant+CD4%28%2B%29+T-cell+response+to+Helicobacter+pylori+reduces+risk+for+gastric+disease+in+humans%5BTitle%5D)+AND+%22Gastroenterology%22%5BJournal%5D)">A dominant CD4(+) T-cell response to Helicobacter pylori reduces risk for gastric disease in humans.</a> Gastroenterology. 144 (3), 591-600 (2013).</li>
</ol>

The authors have nothing to disclose.

This protocol provides an efficient method for the in vitro culture of duck antigen-specific T cells and also establishes an intracellular cytokine staining protocol for ducks, which can be used to assess the effector responses of T cells. Currently, there are no published reports on in vitro culture protocols for duck T cells. We primarily referenced protocols for human antigen-specific T cells but are committed to optimizing the incubation conditions for APCs. We are considering further optimization o...

The process of T cell activation, proliferation, differentiation, and conversion into memory T cells is central to antigen-specific immune responses1. Initially, T cells are activated when their T cell receptors (TCR) recognize antigenic peptides presented on the surface of antigen-presenting cells (APCs) by major histocompatibility complex (MHC) molecules2,3. This activation process requires not only the binding of TCR to MHC molecules but also the coordination of co-stimulatory signals, which are crucial for fully activating T cell functions4. Once activated, T cells quickly enter the proliferation phase, generating numerous clones that share the same antigen specificity as the original T cell. During this proliferation phase, T cells further differentiate based on their function, primarily into CD8+ T cells and CD4+ T cells5. These differentiated cells mediate cytotoxic killing and assist immune responses, respectively. Following the initial infection, a portion of the activated T cells transform into long-lived memory T cells6. These memory T cells can persist in the immune system for extended periods, rapidly responding to the same pathogen upon re-exposure. As a result, they generate a stronger and more efficient immune response, providing long-term immune protection for the host7. This entire process is critical for the design of T-cell vaccines, as it helps improve vaccine efficacy and durability8.
In this context, cultivating antigen-specific T cells in vitro becomes essential. This protocol was developed based on established methods for in vitro culture of human T cells, with necessary adaptations for the avian immune system9. By growing these cells outside of the body, researchers can study the T cell response under different immune states, such as activation, proliferation, differentiation, and memory formation10. This in vitro approach is invaluable for understanding the roles T cells play in immune responses. Furthermore, under in vitro culture conditions, the secretion of cytokines (such as IFN-&#947;) by T cells can be monitored11,12. This monitoring is crucial for assessing the quality, intensity, and persistence of immune responses, as well as studying interactions between T cells and other immune cells. Additionally, in vitro expansion of antigen-specific T cells enables large-scale enrichment, increases the sensitivity of detection, and enhances the assessment of T cell response levels13. Thus, in vitro culture of antigen-specific T cells serves as a powerful tool to better understand the role of poultry T cells in immune responses, which increases the sensitivity of detection and enhances the assessment of T cell response levels. While similar in vitro methods have been well established in mammalian systems, the application of such techniques in avian species remains limited. This is especially relevant in poultry immunology, where tools for analyzing T cell responses are underdeveloped. Ducks, in particular, serve as natural reservoirs for several avian influenza viruses, yet little is known about their antigen-specific T cell immunity. Therefore, developing a standardized in vitro T cell culture protocol tailored to avian systems is essential for advancing both basic research and applied immunology in poultry.
A key cytokine involved in these processes is IFN-&#947;, a type II interferon primarily produced by CD8+ T cells, type 1 CD4+ T cells, and NK cells14. IFN-&#947; plays a crucial role in inhibiting viral replication and regulating immune responses15. The expression level of IFN-&#947; reflects the immune status and serves as a marker for T cell activation, enabling researchers to assess T cell response levels through its expression16,17. One common method for detecting cytokine expression in immune cells is intracellular cytokine staining (ICS)18,19. However, due to limitations in experimental materials and techniques, research on ducks has lagged behind that of mammals5. At present, many researchers rely on qPCR to measure IFN-&#947; expression levels, though this method has certain limitations11. In our lab, we successfully developed an antibody for duck IFN-&#947; that is compatible with flow cytometry. Building on that success, in this study, we established an ICS method to detect IFN-&#947; protein expression in duck T cells, providing a reliable tool for further study on duck T cell responses.

<table><tbody><tr><td>1.5 mL MICRO-Centrifuge tubes</td><td>Biosharp</td><td>Cat#BS-15-M</td><td></td></tr><tr><td>15 mL Centrifuge tubes</td><td>Labselect</td><td>Cat#CT-002-15A</td><td></td></tr><tr><td>2-mercaptoethanol (55 mM)</td><td>Sigma-Aldrich</td><td>Cat#M6250-100ML</td><td></td></tr><tr><td>48-Well tissue culture plate (No treated, flat bottom)</td><td>Biofil</td><td>Cat#TCP000048</td><td></td></tr><tr><td>50 mL Centrifuge tubes</td><td>Labselect</td><td>Cat#CT-002-50A</td><td></td></tr><tr><td>96-well Unskirted qPCR Plates</td><td>Labselect</td><td>Cat#PP-96-NS-0100</td><td></td></tr><tr><td>BD Cytofix/Cytoperm kit</td><td>BD Bioscience</td><td>Cat#BD 554714</td><td></td></tr><tr><td>Brefeldin A (BFA)</td><td>BD Bioscience</td><td>Cat#347688</td><td></td></tr><tr><td>Cell culture CO&lt;sub&gt;2&lt;/sub&gt; incubator</td><td>Thermo Fisher</td><td>Heracell 150i GP</td><td></td></tr><tr><td>Centrifuge</td><td>Eppendorf</td><td>5810R</td><td></td></tr><tr><td>CFSE-labeling kit</td><td>Abcam</td><td>Cat#ab113853</td><td></td></tr><tr><td>ChamQ SYBR qPCR Master Mix</td><td>Vazyme</td><td>Cat#Q341-02</td><td></td></tr><tr><td>Duck peripheral blood lymphocyte isolation kit</td><td>Tbdscience</td><td>Cat#LTS1090D</td><td></td></tr><tr><td>Evo M-MLV RT Premix</td><td>Accurate Biotechnology</td><td>Cat#AG11706</td><td></td></tr><tr><td>FastPure Cell/Tissue Total RNA Isolation Kit V2</td><td>Vazyme</td><td>Cat#RC112-01</td><td></td></tr><tr><td>Fetal Bovine Serum</td><td>Gibco</td><td>Cat#10437-028</td><td></td></tr><tr><td>Flow cytometer</td><td>Beckman Coulter</td><td>BA43347</td><td></td></tr><tr><td>Flow Tube</td><td>Beyotime</td><td>Cat#FFC005</td><td></td></tr><tr><td>FlowJo v10.8.1</td><td>Tree Star</td><td>https://www.flowjo.com</td><td></td></tr><tr><td>Goat Anti-Mouse 488, 1:50 dilution</td><td>Abbkine</td><td>Cat#A23210</td><td></td></tr><tr><td>Goat Anti-Mouse IgG2b, FITC, 1:50 dilution</td><td>Southern Biotech</td><td>Cat#1091-31</td><td></td></tr><tr><td>Goat Anti-Mouse IgG3, PE, 1:250 dilution</td><td>Southern Biotech&amp;nbsp;</td><td>Cat#1100-09S</td><td></td></tr><tr><td>GraphPad prism 8.0.2</td><td>GraphPad Software</td><td>https://www.graphpad-prism.cn</td><td></td></tr><tr><td>H5N1 AIV strain DK383</td><td>National and Regional Joint Engineering Laboratory for Medicamen of Zoonosis Prevention and Control</td><td>A/Duck/Guangdong/383/2008</td><td></td></tr><tr><td>L-glutamine (200 mM)</td><td>Gibco</td><td>Cat#25030081</td><td></td></tr><tr><td>Microscope</td><td>Motic</td><td>AE2000</td><td></td></tr><tr><td>Mouse Anti-Duck CD4, 1:50 dilution</td><td>Bio-Rad</td><td>Cat#MCA2478</td><td></td></tr><tr><td>Mouse Anti-Duck CD8&amp;alpha;, 1:50 dilution</td><td>GeneTex&amp;nbsp;</td><td>Cat#GTX41834</td><td></td></tr><tr><td>Mouse Anti-Duck IFN-&amp;gamma; mAb, 1:10 dilution</td><td>Prepared in our laboratory&amp;nbsp;</td><td>NA</td><td></td></tr><tr><td>NanoDrop One Spectrophotometer</td><td>Thermo Fisher</td><td>AZY1603209</td><td></td></tr><tr><td>NEAA (non-essential</td><td>Gibco</td><td>Cat#11140-050</td><td></td></tr><tr><td>PBS</td><td>Gibco</td><td>Cat#10010023</td><td></td></tr><tr><td>PCR Thermal Cycler</td><td>Biometra</td><td>Biometra Tone 96G</td><td></td></tr><tr><td>Penicillin-streptomycin solution</td><td>Gibco</td><td>Cat#15070063</td><td></td></tr><tr><td>Real-Time PCR system</td><td>Applied Biosystems</td><td>ABI7500</td><td></td></tr><tr><td>recombinant human IL-2 (10 &amp;mu;g)</td><td>USCNK</td><td>Cat#RPA111Ga01</td><td></td></tr><tr><td>Red Blood Cell Lysis Buffer</td><td>Tbdscience</td><td>Cat#NH4CL2009</td><td></td></tr><tr><td>RPMI 1640</td><td>Gibco</td><td>Cat#11875-119</td><td></td></tr><tr><td>Sodium pyruvate (100 mM)</td><td>Gibco</td><td>Cat#11360-070</td><td></td></tr><tr><td>Trypan Blue</td><td>Sigma-Aldrich</td><td>Cat#93595</td><td></td></tr><tr><td>Two-week-old mallard ducks (Sheldrake)</td><td>a duck farm in Guangzhou</td><td>NA</td><td></td></tr></tbody></table>

in vitro culture for h5n1-specific duck t cells and detection of immune responses using intracellular cytokine staining method

In Vitro Culture for H5N1-Specific Duck T Cells and Detection of Immune Responses Using Intracellular Cytokine Staining Method

The in vitro culture of T cells is a critical method for studying immune responses, viral infections, and potential therapeutic strategies. However, no established protocols for culturing avian T cells in vitro have been reported to date. In this study, we present a protocol for the first time, utilizing the highly pathogenic avian influenza (HPAIV) H5N1 virus as a model. Here, 4-week-old ducks were infected with the virus, and memory T lymphocytes were isolated 28 days post-infection to culture H5N1-specific duck T lymphocytes, enabling the investigation of the specific immune response to the H5N1 virus. Key steps in the protocol include isolating memory peripheral blood mononuclear cells (PBMCs) from infected ducks, activating antigen-presenting cells (APCs) with an optimal multiplicity of infection (MOI = 5) for 6 h, and preparing T cell culture media supplemented with recombinant IL-2 and other specific additives. T-cell proliferation, cytokine secretion, and cytotoxic activity were closely monitored throughout the process. Additionally, we established an intracellular cytokine staining protocol to quantify IFN-&#947; secretion in duck T cells. This involved generating a hybridoma cell line expressing IgG3&#954; antibodies specific to duck IFN-&#947;, followed by successful antibody purification. The purified antibody was diluted 1:10 and applied in flow cytometry to precisely measure IFN-&#947; secretion. This method offers a reliable tool for evaluating duck T cell responses and lays the foundation for future investigations into avian viral immunology.

This protocol was developed based on an earlier study on the detection of antigen-specific T cell effector responses in ducks20. The first step of the experiment involves the in vitro culture of virus-specific T cells, which serve as the foundation for subsequent effector response studies. Initially, APCs were incubated and co-cultured with effector cells. Morphological observations revealed that after proliferation, the cells exhibited cluster growth (Figure 2A</stro...

The protocol describes a method for culturing avian T cells in vitro by isolating memory T cells from infected ducks, allowing for the generation of highly purified specific duck T cells. Additionally, an intracellular cytokine staining (ICS) method was established to accurately measure IFN-&#947; secretion in duck T cells.

The in vitro culture of T cells is a critical method for studying immune responses, viral infections, and potential therapeutic strategies. However, no ...

in-vitro-culture-for-h5n1-specific-duck-t-cells-detection-immune

Research

JoVE Journal

Immunology and Infection

Unlike cell-free HIV-1 particles, infected CD4+ T cells are effectively sensed by plasmacytoid dendritic cells (pDCs). This manuscript describes a method where peripheral blood mononuclear cells (PBMCs) or isolated pDCs are co-cultured with HIV-1 infected T cells to evaluate innate sensing by pDCs as assessed by release of type-I IFN.

Assessing the Innate Sensing of HIV-1 Infected CD4+ T Cells by Plasmacytoid Dendritic Cells Using an Ex vivo Co-culture System.

The ability to monitor T cell responses in detail in vivo is important for the development of our understanding of the immune response. Here we describe the use of fluorescent target arrays (FTAs) in an in vivo T cell assay that assesses &gt;250 parameters simultaneously by flow cytometry.

The Use of Fluorescent Target Arrays for Assessment of T Cell Responses In vivo

Two flow cytometry-based methods – an in vitro T cell priming assay and intracellular cytokine staining were utilized to measure antigen presenting capacity of dendritic cells and antigen-specific T cell responses to a West Nile virus mutant infection in mice.

In Vitro Analysis of Myd88-mediated Cellular Immune Response to West Nile Virus Mutant Strain Infection

There is an overall lack of knowledge about how vaccines work. Here we propose the combined use of reverse genetics and bone marrow chimeric mice to gain insight into the early host immune responses to vaccines with a special focus on dendritic cells and T cell immunity.

Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity

Influenza A viruses (IAVs) are important human respiratory pathogens. To understand the pathogenicity of IAVs and to perform preclinical testing of novel vaccine approaches, animal models mimicking human physiology are required. Here, we describe techniques to evaluate IAV pathogenesis, humoral responses and vaccine efficacy using a mouse model of infection.

Influenza A Virus Studies in a Mouse Model of Infection

We describe a method to measure the activation of Fc-mediated effector functions by antibodies that target the influenza virus hemagglutinin. This assay can also be adapted to assess the ability of monoclonal antibodies or polyclonal sera targeting other viral surface glycoproteins to induce Fc-mediated immunity.

A Method to Assess Fc-mediated Effector Functions Induced by Influenza Hemagglutinin Specific Antibodies

This paper describes protocols of evaluating Tfh and GC B response in mouse model of influenza virus infection.

Evaluation of T Follicular Helper Cells and Germinal Center Response During Influenza A Virus Infection in Mice

This protocol describes an experimental process to produce high-titer infectious viral pseudotyped particles (pp) with envelope glycoproteins from two influenza A strains and how to determine their infectivity. This protocol is highly adaptable to develop pps of any other type of enveloped viruses with different envelope glycoproteins.

Production of High-Titer Infectious Influenza Pseudotyped Particles with Envelope Glycoproteins from Highly Pathogenic H5N1 and Avian H7N9 Viruses

This protocol details an investigation of the early interactions between virally infected nasal epithelial cells and innate cell activation. Individual subsets of immune cells can be distinguished based on their activation in response to viral infections. They can then be further investigated to determine their effects on early antiviral responses.

Contact-Free Co-Culture Model for the Study of Innate Immune Cell Activation During Respiratory Virus Infection

Here we describe a protocol for pseudovirus packaging and the measurement of antibody neutralizing activity.

Preparation of Pseudo-Typed H5 Avian Influenza Viruses with Calcium Phosphate Transfection Method and Measurement of Antibody Neutralizing Activity

The current study showcases protocols for assessing the early fate commitment of virus-specific TFH cells and manipulating gene expression in these cells.

Accessing Early Differentiation of Virus-Specific Follicular Helper CD4+ T Cell in Acute LCMV-Infected Mice

Learn to culture H5N1-specific duck T cells in vitro and detect IFN-γ responses using intracellular cytokine staining. This protocol enables quantification of avian T cell immunity for vaccine development.

In Vitro Culture for H5N1-Specific Duck T Cells and Detection of Immune Responses Using Intracellular Cytokine Staining Method

Explore More Videos